Merck | MRK - Creditori Commerciali

Prezzo Delle Azioni
115.79
Cambio Giornaliero
0.36 0.31%
Mensile
-4.82%
Annuale
22.24%
Q1 Previsione
112.12




Creditori Commerciali Cambiamento Data
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.12B 183M 2025-09
ALKERMES USD 107.95M 39.95M 2025-12
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Biogen USD 432M 18.9M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Coherus Biosciences USD 9.91M 14.98M 2025-12
Drreddys Laboratories INR 454.04M 854K 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 21.07B 7.42B 2025-09
J&J USD 11.99B 2.37B 2025-12
Medtronic USD 2.58B 26M 2025-09
Merck USD 4.15B 102M 2025-09
Novartis USD 4.56B 49M 2025-09
Novartis USD 4.56B 49M 2025-09
Novo Nordisk DKK 19.76B 4.15B 2025-12
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
Phibro Animal Health USD 133.3M 2.7M 2025-12
Prestige Brands USD 42.95M 1.02M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.93B 927M 2025-12
Sanofi EUR 22.93B 2.89B 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
Zoetis USD 487M 77M 2025-12